BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 30573039)

  • 1. The current approach to the diagnosis of myelodysplastic syndromes
    Weinberg OK; Hasserjian RP
    Semin Hematol; 2019 Jan; 56(1):15-21. PubMed ID: 30573039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How I Diagnose Low-Grade Myelodysplastic Syndromes.
    Siddon AJ; Hasserjian RP
    Am J Clin Pathol; 2020 Jun; 154(1):5-14. PubMed ID: 32458977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and classification of myelodysplastic syndromes.
    Hasserjian RP; Germing U; Malcovati L
    Blood; 2023 Dec; 142(26):2247-2257. PubMed ID: 37774372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetics and molecular genetics of myelodysplastic neoplasms.
    Ning Y; Zhang Y; Kallen MA; Emadi A; Baer MR
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101512. PubMed ID: 38092472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of flow cytometry in detecting dysplasia of myelodysplastic syndromes].
    Li J; He GS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1069-72. PubMed ID: 23998614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of flow cytometric immunophenotyping in myelodysplastic syndromes.
    Pagnucco G; Giambanco C; Gervasi F
    Ann N Y Acad Sci; 2006 Nov; 1089():383-94. PubMed ID: 17261782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndromes.
    Zhou J; Orazi A; Czader MB
    Semin Diagn Pathol; 2011 Nov; 28(4):258-72. PubMed ID: 22195404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic/myeloproliferative neoplasms: are morphology and immunophenotyping still relevant?
    Sangiorgio VFI; Orazi A; Arber DA
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101139. PubMed ID: 32460987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative review of classification systems in myelodysplastic syndromes (MDS).
    Bennett JM
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic Characteristics of Myelodysplastic Syndromes.
    Yuen LD; Hasserjian RP
    Clin Lab Med; 2023 Dec; 43(4):577-596. PubMed ID: 37865504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
    Garcia-Manero G
    Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelodysplastic syndromes: pathophysiology, clinical and biological features].
    Becha M; Braham Jmili N
    Ann Biol Clin (Paris); 2015; 73(6):643-56. PubMed ID: 26635046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes.
    Verigou E; Lampropoulou P; Smyrni N; Kolliopoulou G; Sakellaropoulos G; Starakis I; Zikos P; Solomou E; Symeonidis A; Karakantza M
    Cardiovasc Hematol Disord Drug Targets; 2015; 15(2):148-61. PubMed ID: 26126819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics in myelodysplastic syndromes.
    Haferlach T
    Leuk Res; 2012 Dec; 36(12):1459-62. PubMed ID: 22986016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myelodysplastic syndromes--an overview for the practitioner].
    Solenthaler M; Tobler A
    Ther Umsch; 2004 Feb; 61(2):117-24. PubMed ID: 15018394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. World Health Organization classification of myelodysplastic syndromes.
    Czader M; Orazi A
    Curr Pharm Des; 2012; 18(22):3149-62. PubMed ID: 22571693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphology, cytogenetics and classification of MDS.
    Giagounidis A; Haase D
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):337-53. PubMed ID: 24507811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostics and Prognostication of Myelodysplastic Syndromes.
    Zini G
    Ann Lab Med; 2017 Nov; 37(6):465-474. PubMed ID: 28840983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes.
    Merchant SH; Gonchoroff NJ; Hutchison RE
    Cytometry; 2001 Feb; 46(1):28-32. PubMed ID: 11241504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.